1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient and tumor characteristics
Characteristics No. of Patients % Age (yr) (mean) (range) 51 (33–80) Sex Male 38 83 Female 8 17 Neck dissection procedure SOHND 33 72 MRND 13 28 Bilateral MRND 1 2 Pathologic T stage T1–2 33 72 T3–4 13 28 Pathologic N stage N0 32 70 N1–3 14 30 Pathologic differentiation Well 15 33 Moderate 27 59 Poor 4 9 Pathologic ECS Present 10 22 Absent 36 78 Postoperative treatment RT 7 15 CCRT 18 39
Note:—SOHND indicates supraomohyoid neck dissection; MRND, modified radial neck dissection; ECS, extracapsular spread; RT, radiotherapy; CCRT, concurrent chemoradiotherapy.